These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2553494)

  • 1. In vitro interaction of mutagenic chromium (VI) with red blood cells.
    Branca M; Dessi A; Kozlowski H; Micera G; Serra MV
    FEBS Lett; 1989 Oct; 257(1):52-4. PubMed ID: 2553494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of 51Cr-chromate by human erythrocytes-a role of glutathione.
    Aaseth J; Alexander J; Norseth T
    Acta Pharmacol Toxicol (Copenh); 1982 Apr; 50(4):310-5. PubMed ID: 7102348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESR characterization and metallokinetic analysis of Cr(V) in the blood of rats given carcinogen chromate(VI) compounds.
    Sakurai H; Takechi K; Tsuboi H; Yasui H
    J Inorg Biochem; 1999 Jul; 76(1):71-80. PubMed ID: 10530008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo formation of chromium(V) in chick embryo liver and red blood cells.
    Liebross RH; Wetterhahn KE
    Carcinogenesis; 1992 Nov; 13(11):2113-20. PubMed ID: 1330350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of hexavalent chromium by bovine erythrocytes and its interaction with cytoplasmic components; the role of glutathione.
    Kitagawa S; Seki H; Kametani F; Sakurai H
    Chem Biol Interact; 1982 Jul; 40(3):265-74. PubMed ID: 6282472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the erythrocyte anion carrier by chromate.
    Buttner B; Beyersmann D
    Xenobiotica; 1985; 15(8-9):735-41. PubMed ID: 4072261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction with glutathione is a weakly mutagenic pathway in chromium(VI) metabolism.
    Guttmann D; Poage G; Johnston T; Zhitkovich A
    Chem Res Toxicol; 2008 Nov; 21(11):2188-94. PubMed ID: 18808157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of Cr(VI) adsorption by coir pith studied by ESR and adsorption kinetic.
    Suksabye P; Nakajima A; Thiravetyan P; Baba Y; Nakbanpote W
    J Hazard Mater; 2009 Jan; 161(2-3):1103-8. PubMed ID: 18513862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism of the chromate reduction by glutathione: ESR evidence for the glutathionyl radical and an isolable Cr(V) intermediate.
    Shi XL; Dalal NS
    Biochem Biophys Res Commun; 1988 Oct; 156(1):137-42. PubMed ID: 2845969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromate effects on human erythrocytes--investigations on sulphydryl groups, cross-linking of membrane proteins and electromechanical properties in the coulter-counter.
    Buttner B; Hebeler M; Beyersmann D
    Sci Total Environ; 1988 Jun; 71(3):555-60. PubMed ID: 3406723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relatively long-lived chromium(V) species are produced by the action of glutathione on carcinogenic chromium(VI).
    Goodgame DM; Joy AM
    J Inorg Biochem; 1986 Mar; 26(3):219-24. PubMed ID: 3009713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glutathione depletion on formation of paramagnetic chromium in Chinese hamster V-79 cells.
    Sugiyama M; Tsuzuki K
    FEBS Lett; 1994 Mar; 341(2-3):273-6. PubMed ID: 8137952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of the reaction of chromate with metallothionein.
    Krepkiy D; Antholine WE; Petering DH
    Chem Res Toxicol; 2003 Jun; 16(6):750-6. PubMed ID: 12807358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromate-induced human erythrocytes haemoglobin oxidation and peroxidation: influence of vitamin E, vitamin C, salicylate, deferoxamine, and N-ethylmaleimide.
    Fernandes MA; Geraldes CF; Oliveira CR; Alpoim MC
    Toxicol Lett; 2000 Apr; 114(1-3):237-43. PubMed ID: 10713489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular chromium reduction.
    Arslan P; Beltrame M; Tomasi A
    Biochim Biophys Acta; 1987 Oct; 931(1):10-5. PubMed ID: 2820507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially deadly carcinogenic chromium redox cycle involving peroxochromium(IV) and glutathione.
    Marin R; Ahuja Y; Bose RN
    J Am Chem Soc; 2010 Aug; 132(31):10617-9. PubMed ID: 20681676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate.
    Quievryn G; Messer J; Zhitkovich A
    Carcinogenesis; 2006 Nov; 27(11):2316-21. PubMed ID: 16714765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenic chromium(VI)-induced protein oxidation and lipid peroxidation: implications in DNA-protein crosslinking.
    Mattagajasingh SN; Misra BR; Misra HP
    J Appl Toxicol; 2008 Nov; 28(8):987-97. PubMed ID: 18615841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromium (IV)-mediated fenton-like reaction causes DNA damage: implication to genotoxicity of chromate.
    Luo H; Lu Y; Shi X; Mao Y; Dalal NS
    Ann Clin Lab Sci; 1996; 26(2):185-91. PubMed ID: 8852428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-frequency EPR study of chromium(V) formation from chromium(VI) in living plants.
    Liu KJ; Jiang J; Shi X; Gabrys H; Walczak T; Swartz HM
    Biochem Biophys Res Commun; 1995 Jan; 206(3):829-34. PubMed ID: 7832793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.